Acadia Healthcare Beats Q1, Faces Q2 Challenges

Acadia Healthcare exceeded Q1 2026 revenue expectations, reporting $828.8 million, a 7.6% increase from last year. Adjusted earnings per share hit $0.37, surpassing forecasts by nearly 40%. However, Q2 guidance fell short, causing a stock drop. The company saw strong growth in acute inpatient psychiatric services, but faced challenges in specialty facilities and higher payer denials. Despite these issues, Acadia maintained full-year revenue and EPS guidance, with an EBITDA outlook topping estimates. The company is focusing on new facilities, underperformer improvements, and tech solutions to manage payer risks. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/024e7110d8aed532